Management of the hyperlipidemic patient.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D004035:Diet Therapy; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D008052:Lipid Metabolism, Inborn Errors / Q000175:diagnosis; D008055:Lipids / Q000097:blood*; D008661:Metabolism, Inborn Errors / Q000175:diagnosis; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D004967:Estrogens; D008055:Lipids; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D002784:Cholesterol; D002994:Clofibrate